Home  /  Resource Library  /  Lisocabtagene maraleucel in relapsed or refractory diffuse large B-cell lymphoma: What is the evidence?

Lisocabtagene maraleucel in relapsed or refractory diffuse large B-cell lymphoma: What is the evidence?

Review article examines the effectiveness of CAR T therapy Lisocabtagene maraleucel for treatment of relapsed diffuse large b-cell lymphoma.